BIOGRAPHY
Dr. Jennifer Specht is an Associate Professor in the Division of Medical Oncology at the University of Washington and an Associate Member of the Clinical Research Division at Fred Hutchinson Cancer Research Center. Dr. Specht leads the Phase I Breast Cancer Program and sees patients in the Bezos Immunotherapy Clinic, both at Seattle Cancer Care Alliance. Her research interests include novel therapies for triple-negative (ER, PR, and HER2 negative) breast cancer, immunotherapy (both targeted and cellular) for breast cancer, molecular imaging with FDG PET and DCE-MRI to understand in vivo biology of locally-advanced and inflammatory breast cancer, and use of FDG PET to assess response to therapy in bone-dominant metastatic breast cancer.